Mark Schoenberg, Chief Medical Officer at UroGen Pharma Ltd. (URGN), sold 871 shares at $42.92 ($37K) on 2026-09-08, disclosed to the SEC on 2026-09-09.
Open-market sale of $37k URGN by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| URGN | SELL | 2026-06-24 | $350K | — | Filing → |
| URGN | SELL | 2026-06-09 | $143K | — | Filing → |
| URGN | SELL | 2026-05-11 | $300K | — | Filing → |